Steven Grinspoon

Steven Grinspoon, MD, is a leading physician scientist at Harvard Medical School and Chief of the Metabolism Unit at Massachusetts General Hospital (MGH). He serves as Director of the Nutrition Obesity Research Center at Harvard, focusing on metabolic disorders in HIV patients and obesity-related conditions.

• Current affiliations: Harvard University, Massachusetts General Hospital
• Academic rank: Physician Scientist

His research explores metabolic consequences of visceral fat accumulation, particularly in HIV lipodystrophy. Dr. Grinspoon investigates growth hormone-releasing hormone (GHRH) therapies to reduce cardiovascular risk and visceral fat, with significant contributions to understanding HIV-associated metabolic disorders.

Recent publications highlight his work on cardiovascular risk underestimation in HIV populations (2025), diabetes risk factors in HIV patients (2024), and therapies targeting visceral fat reduction (2014). Earlier studies (2008, 2012) established protocols for growth hormone interventions and arterial inflammation in HIV.

Dr. Grinspoon's work bridges clinical research with real-world applications, influencing global HIV treatment guidelines and metabolic risk management strategies. His collaborations span infectious disease, endocrinology, and cardiology disciplines.